BAK
Braskem S.A.
BAK lost money over the past year, so it has no meaningful PE right now.
BAK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Weak |
BAK's revenue and profitability are currently stable, but its cash flow and balance sheet are weak.
BAK PE Valuation
BAK has no meaningful PE right now: it lost money over the past year.
BAK Forward outlook
There aren't enough analyst estimates for BAK to show an outlook.
BAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.55 | +$0.06 |
| Q1 2026 | -$4.17 | $0.00 |
| Q4 2025 | -$4.50 | +$0.59 |
| Q3 2025 | -$2.35 | +$0.91 |
| Q2 2025 | -$2.61 | +$1.47 |
| Q1 2025 | -$4.17 | -$1.42 |
| Q4 2024 | -$5.09 | -$3.03 |
| Q3 2024 | -$3.26 | -$1.14 |
BAK is still losing money, but less than at its worst: $2.55 per share over the past year, against $5.09 at its worst in late 2024.
BAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.9B | +22% |
| Q1 2026 | $2.8B | -20% |
| Q4 2025 | $2.9B | -16% |
| Q3 2025 | $3.1B | -19% |
| Q2 2025 | $3.2B | -6.4% |
| Q1 2025 | $3.5B | +8.6% |
| Q4 2024 | $3.4B | +15% |
| Q3 2024 | $3.8B | +28% |
BAK's revenue is recovering but still below its 2021 peak: $3.9B last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 18% | +24 points |
| Q1 2026 | -1.4% | -1.9 points |
| Q4 2025 | 0.7% | +2.3 points |
| Q3 2025 | -5.4% | -10 points |
| Q2 2025 | -5.4% | -4.5 points |
| Q1 2025 | 0.5% | +0.7 points |
| Q4 2024 | -1.6% | +4.3 points |
| Q3 2024 | 4.8% | +8.5 points |
BAK's operating margin was 18% last quarter, up 24 points from the same quarter a year ago.
BAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$95.8M | +$71.3M |
| Q1 2026 | -$864.9M | -$330.5M |
| Q4 2025 | -$265.7M | -$227.2M |
| Q3 2025 | -$349.3M | -$57.5M |
| Q2 2025 | -$167M | -320% |
| Q1 2025 | -$534.4M | -3242% |
| Q4 2024 | -$38.5M | +$895.2K |
| Q3 2024 | -$291.8M | +$368.5M |
BAK has burned cash in eight of the last eight quarters: −$1.6B over the past year, against −$1B the year before.
BAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.9x | High |
| Q1 2026 | 9.7x | High |
| Q4 2025 | 9.8x | High |
| Q3 2025 | 16.9x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 2,506.9x | High |
| Q1 2024 | 78.8x | High |
| Q4 2023 | 17.1x | High |
BAK's net debt is about 6.9 years of its operating earnings (EBITDA), down from 9.4 years a year ago.
BAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.3 | Neutral |
| Stochastic | 20.1 | Neutral |
BAK's weekly RSI is 32 (neutral) and its Stochastic is 20 (neutral).
BAK PE vs Basic Materials Sector
BAK has no meaningful PE right now: it lost money over the past year.
BAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.46 | 23% below |
| 20 week MA | $1.88 | 40% below |
| 50 week MA | $2.91 | 61% below |
| 100 week MA | $3.19 | 65% below |
| 200 week MA | $5.57 | 80% below |
BAK is in a downtrend: it's below all five of its weekly moving averages, and 80% below its 200-week average.
BAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.0 | $8.86 | -41% |
| 2021 | $8.86 | $20.1 | +127% |
| 2022 | $20.1 | $9.29 | -54% |
| 2023 | $9.29 | $8.82 | -5.1% |
| 2024 | $8.82 | $3.80 | -57% |
| 2025 | $3.80 | $2.93 | -23% |
| 2026 YTD | $2.93 | $1.13 | -61% |
BAK has finished four years in a row lower, and it's down 61% so far in 2026.